This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2000-2004.
Location History:
- Clinton, IN (US) (2000)
- Midland, MI (US) (2004)
Company Filing History:
Years Active: 2000-2004
Title: The Innovations of Daniel Edward Verral, II
Introduction
Daniel Edward Verral, II is an accomplished inventor based in Clinton, IN (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds and processes. With a total of 3 patents to his name, Verral continues to push the boundaries of innovation.
Latest Patents
Verral's latest patents include groundbreaking work on Pyrrolo [3,2-b]pyridine processes and intermediates. This invention provides processes and intermediates for the preparation of 5-amino-3-(1-methylpiperidin-4-yl)pyrrolo-[3,2-b]pyridine. Additionally, he has developed cyclic peptide antifungal agents, which involve phosphonylating agents and conditions that are compatible with acid- and base-sensitive compounds. This work promotes a regioselective and reproducible conversion to phosphonate compounds, along with intermediates for preparing phosphonate derivatives of cyclic peptide antifungal agents.
Career Highlights
Verral is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to contribute to important advancements in medicinal chemistry.
Collaborations
Throughout his career, Verral has collaborated with notable colleagues, including Uko Effiong Udodong and John Leo Grutsch, Jr. These collaborations have further enriched his research and development efforts.
Conclusion
Daniel Edward Verral, II exemplifies the spirit of innovation in the field of chemistry. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and developing new therapeutic agents.